ALBT Stock Summary and Trading Ideas (Avalon Globocare Corp. | NASDAQ:ALBT)

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Corp. trades on the NASDAQ stock market under the symbol ALBT.

As of December 20, 2024, ALBT stock price declined to $3.42 with 46,364 million shares trading.

ALBT has a beta of 0.75, meaning it tends to be less sensitive to market movements. ALBT has a correlation of 0.01 to the broad based SPY ETF.

ALBT has a market cap of $3.74 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ALBT belongs to (by Net Assets): VXF.

ALBT has underperformed the market in the last year with a price return of -53.6% while the SPY ETF gained +27.8%. However, in the short term, ALBT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +11.2% vs +4.4% return in SPY. But in the last 2 weeks, ALBT shares have been beat by the market, returning -17.0% compared to an SPY return of -2.4%.

ALBT support price is $3.36 and resistance is $4.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALBT shares will trade within this expected range on the day.